Skip to main content
search

Bevin Newman is a partner in the Antitrust and Competition Practice Group in the firm’s Washington, D.C. office.

Bevin is a strategic adviser to clients in cutting-edge affiliations and collaborative arrangements. She focuses much of her practice in the healthcare industry, bringing over 20 years of experience advising and defending globally renowned health systems, academic medical centers, providers, payers and pharmaceuticals companies undertaking significant transactions, including mergers and acquisitions, joint ventures, intellectual property licenses and innovative alliances, as well as on conduct matters. She represents clients before the Federal Trade Commission, the Department of Justice and state attorneys general on complex antitrust matters.

Bevin also has extensive experience coordinating the merger-control, foreign direct investment (CFIUS) and regulatory reviews of multi-jurisdictional transactions for U.S. and foreign clients in the pharmaceutical, medical device, technology and energy industries. She is one of the most experienced Hart-Scott-Rodino Act (HSR Act) practitioners in the country. She has advised on multiple antitrust matters for Caremark, Cigna, UPMC, Duke University, Yale-New Haven Health System, Centura, SSM Health, UnityPoint, Abbot Laboratories, Boehringer Ingelheim, Sumitomo Dainippon Pharmaceuticals and Bon Secours Mercy Health.


+1-202-747-1940

Bevin M.B. Newman

Partner
Sheppard Mullin
Washington, DC

Practice Area: Antitrust, M&A

All-Star

ALL-STAR BIOGRAPHY

Bevin Newman is a partner in the Antitrust and Competition Practice Group in the firm’s Washington, D.C. office.

Bevin is a strategic adviser to clients in cutting-edge affiliations and collaborative arrangements. She focuses much of her practice in the healthcare industry, bringing over 20 years of experience advising and defending globally renowned health systems, academic medical centers, providers, payers and pharmaceuticals companies undertaking significant transactions, including mergers and acquisitions, joint ventures, intellectual property licenses and innovative alliances, as well as on conduct matters. She represents clients before the Federal Trade Commission, the Department of Justice and state attorneys general on complex antitrust matters.

Bevin also has extensive experience coordinating the merger-control, foreign direct investment (CFIUS) and regulatory reviews of multi-jurisdictional transactions for U.S. and foreign clients in the pharmaceutical, medical device, technology and energy industries. She is one of the most experienced Hart-Scott-Rodino Act (HSR Act) practitioners in the country. She has advised on multiple antitrust matters for Caremark, Cigna, UPMC, Duke University, Yale-New Haven Health System, Centura, SSM Health, UnityPoint, Abbot Laboratories, Boehringer Ingelheim, Sumitomo Dainippon Pharmaceuticals and Bon Secours Mercy Health.

Visit All-Star's Firm »


+1-202-747-1940

Bevin M.B. Newman

Partner
Sheppard Mullin
Washington, DC

Practice Area: Antitrust, M&A

M&A All-Star

WHAT CLIENTS SAY

"Bevin is able to spot problems and think through all possible solutions very efficiently."
"She understands us and Bevin knows how to push a transaction forward."

MY CLIENT PHILOSOPHY

"Embracing both my clients' business vision and competitive realities is the foundation of my approach to providing exceptional service. This requires developing and maintaining a keen understanding of their industry, organization, and priorities as well as deep and current expertise in the law and prevailing enforcement policies. I believe excellent client service means anticipating legal risk and innovating solutions that enable the client to realize the enterprise's goals."

– Bevin M.B. Newman

ALL-STAR BIOGRAPHY

Bevin Newman is a partner in the Antitrust and Competition Practice Group in the firm’s Washington, D.C. office.

Bevin is a strategic adviser to clients in cutting-edge affiliations and collaborative arrangements. She focuses much of her practice in the healthcare industry, bringing over 20 years of experience advising and defending globally renowned health systems, academic medical centers, providers, payers and pharmaceuticals companies undertaking significant transactions, including mergers and acquisitions, joint ventures, intellectual property licenses and innovative alliances, as well as on conduct matters. She represents clients before the Federal Trade Commission, the Department of Justice and state attorneys general on complex antitrust matters.

Bevin also has extensive experience coordinating the merger-control, foreign direct investment (CFIUS) and regulatory reviews of multi-jurisdictional transactions for U.S. and foreign clients in the pharmaceutical, medical device, technology and energy industries. She is one of the most experienced Hart-Scott-Rodino Act (HSR Act) practitioners in the country. She has advised on multiple antitrust matters for Caremark, Cigna, UPMC, Duke University, Yale-New Haven Health System, Centura, SSM Health, UnityPoint, Abbot Laboratories, Boehringer Ingelheim, Sumitomo Dainippon Pharmaceuticals and Bon Secours Mercy Health.

Visit All-Star's Firm »